AT
Actinogen Medical Limited
ATGGF · OTC
$0.04 +0.00% (+$0.00)
Market Cap $185.7M
P/E Ratio -
Div. Yield -
ROE 85.31%
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 8.70x
P/FCF N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 16.77%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROA 52.03%
ROIC 58.92%
Debt
69 /100
Low Current ratio 3.45x
Int. coverage -60.34x
Debt/Equity 0.22x
Stability
56 /100
Moderate Profitable years 0
EPS volatility 11.80%
Beta 0.89x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ATGGF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Steven G. Gourlay
Employees
6
Headquarters
Sydney
Upcoming events
24 FEB
Earnings
Upcoming earnings report